AU5657590A - Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours - Google Patents

Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours

Info

Publication number
AU5657590A
AU5657590A AU56575/90A AU5657590A AU5657590A AU 5657590 A AU5657590 A AU 5657590A AU 56575/90 A AU56575/90 A AU 56575/90A AU 5657590 A AU5657590 A AU 5657590A AU 5657590 A AU5657590 A AU 5657590A
Authority
AU
Australia
Prior art keywords
hydroxamate
beta
tumours
aspartic acid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56575/90A
Other versions
AU660916B2 (en
Inventor
Jacques Grange
Farid Hamedi Sangsari
Nicole Thomasset
Jorge Vila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU5657590A publication Critical patent/AU5657590A/en
Application granted granted Critical
Publication of AU660916B2 publication Critical patent/AU660916B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infections diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumours.
AU56575/90A 1989-04-28 1990-04-27 Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours Ceased AU660916B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (en) 1989-04-28 1989-04-28 D-ASPARTIC ACID-HYDROXAMATE AS A MEDICINAL PRODUCT
FR8905744 1989-04-28
PCT/FR1990/000307 WO1990013291A1 (en) 1989-04-28 1990-04-27 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours

Publications (2)

Publication Number Publication Date
AU5657590A true AU5657590A (en) 1990-11-29
AU660916B2 AU660916B2 (en) 1995-07-13

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56575/90A Ceased AU660916B2 (en) 1989-04-28 1990-04-27 Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours

Country Status (11)

Country Link
EP (1) EP0470144B1 (en)
JP (1) JPH04506796A (en)
AT (1) ATE121935T1 (en)
AU (1) AU660916B2 (en)
CA (1) CA2050936A1 (en)
DE (1) DE69019148T2 (en)
DK (1) DK0470144T3 (en)
ES (1) ES2072431T3 (en)
FR (1) FR2646348A1 (en)
OA (1) OA09519A (en)
WO (1) WO1990013291A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
JP6018752B2 (en) * 2009-09-29 2016-11-02 株式会社 資生堂 Antioxidant composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (en) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES

Also Published As

Publication number Publication date
OA09519A (en) 1992-11-15
AU660916B2 (en) 1995-07-13
EP0470144B1 (en) 1995-05-03
ES2072431T3 (en) 1995-07-16
DE69019148T2 (en) 1995-08-31
CA2050936A1 (en) 1990-10-29
DK0470144T3 (en) 1995-10-02
EP0470144A1 (en) 1992-02-12
FR2646348B1 (en) 1994-04-22
DE69019148D1 (en) 1995-06-08
JPH04506796A (en) 1992-11-26
FR2646348A1 (en) 1990-11-02
ATE121935T1 (en) 1995-05-15
WO1990013291A1 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
AU6270286A (en) Therapeutic nucleosides
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
CA2130360A1 (en) Sulfonic Acid Derivatives in the Treatment of Viral Diseases
IE900073L (en) Treatment of diseases associated with hiv infections
GR3003514T3 (en)
ATE78696T1 (en) MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY.
WO1987007835A1 (en) Drug for treatment and prophylaxis of kidney and liver diseases
PT85885A (en) Process for preparing novel de-acyl a 40926 antibiotics
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2013342A6 (en) Pharmaceutical composition for preventing and treating bacterial or viral diseases.
AU5061090A (en) Aids therapy
UA41338C2 (en) Method for inhibiting retroviral infection caused by human immunodeficiency virus (hiv), method for inhibiting human immunodeficiency virus (hiv)
AU5417696A (en) Substituted tetronic acids useful for treating hiv and other retroviruses
AU2396900A (en) Treatment and prevention of hiv and other viral infections
ATE69551T1 (en) COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS, ESPECIALLY IN ANIMALS.
AU7728296A (en) Hemoregulatory compounds
GEP19991605B (en) Inhibitor, Its Obtaining and Use
MY102905A (en) Therapeutic nucleosides
BG98538A (en) Means for anti-hiv therapy